ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
September 08, 2019Facing claims it induced doctors to prescribe a generic version of GlaxoSmithKline’s Coreg that violated its patents, Teva was hit with a hefty $235 million penalty in 2017. But a federal judge overruled that jury’s verdict last year—and now, one federal
Pharma Sources Insight January 2025
